SARS_CoV_2 mutation literature information.


  Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020.
 PMID: 32895643       2020       Biosafety and health
Introduction: Although there is no evidence from available epidemiological and clinical data that the mutation of S protein D614G leads to increased pathogenicity or virulence of the virus, whether the transmission of the virus is enhanced still needs to be examined by systematic global assessment.
Introduction: Finally, we also need to note whether the epidemic of D614G mutant SARS-CoV-2 is random or naturally selected, as the virus is circulating globally at present.
Introduction: In a recent study, researchers found that a D614G mutation in the SARS-CoV-2 genome enhances the virus's ability to infect human


  BioAider: An efficient tool for viral genome analysis and its application in tracing SARS-CoV-2 transmission.
 PMID: 32904401       2020       Sustainable cities and society
Introduction: Recently, 7 substitution hotspots in SARS-CoV-2, ORF1ab-G10818T (ORF1ab-L3606F), ORF1ab-C8517T, ORF3a-G752T (ORF3a-G251V) S-A1841G (D614G), G171T (Q57H), ORF8-T251C (ORF8-L84S) and N-GGG608_609_610AAC (N-RG203_204KR) have been reported.
Table: D614G
Discussion: The latest study has discovered the strain with substitution of S-D614G could increases the infectivity of SARS-CoV-2.


  Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant.
 PMID: 32905045       2020       Cell reports. Medicine
Introduction: Given that POC antibody tests were designed to detect antibodies to the wild-type S protein, we also aimed to investigate whether SARS-CoV-2 infections with D614G 
Discussion: Demonstration that POC antibody LFA tests can detect the D614G spike mutant is therefore of importance.
Discussion: Of critical importance is the fact that both POC antibody tests (and ELISA) were able to detect antibody responses in patients infected with the D614G Spike mutant and that the band intensity of POC testing increased with neutralization activity in these individuals.


  Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility.
 PMID: 32908978       2020       bioRxiv
Result: 1e), indicating that the D614G mutation does not affect viral replication or virion infectivity on Vero E6 cells.
Result: 1f), indicating that D614G enhances viral replication.
Result: 1h), indicating that the D614G mutation increases the infectivity of SARS-CoV-2 produced from the human lung cell line.


  Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity.
 PMID: 32934770       2020       ACS medicinal chemistry letters
Abstract: Mutation D614G in the spike (S) protein has become dominant, and recent evidence suggests it yields a more stable phenotype with higher transmission efficacy.
Abstract: The D614G substitution creates a sticky packing defect in subunit S1, promoting its association with subunit S2 as a means to stabilize the structure of S1 within the S1/S2 complex.
Introduction: A biophysical/structural analysis of the impact of the D614G


  SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike.
 PMID: 32935099       2020       bioRxiv
Introduction: 5a), suggesting the D614G epitope was not a major antigenic site.
Introduction: SARS-CoV-2 has acquired a D614G mutation within the spike protein and viruses carrying this mutation have since become the dominant circulating strain globally as of early April.
Introduction: These data indicate that the region that encompasses the D614G mutation is not immunodominant or does not affect the antigenicity of epitopes at or near this site.

Browser Board

 Co-occurred Entities




   Filtrator